ALERT: Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.Shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order. X

NEWSROOM

Medtronic Commends CMS on Proposed Rule to Expand Medicare Coverage for All CGMs

October 28, 2020

October 28, 2020 – On October 27th, the Centers for Medicare & Medicaid Services (CMS) announced proposed new changes that, if finalized, would expand Medicare coverage for Continuous Glucose Monitors (CGMs) that provide critical information on glucose levels to help people with diabetes better manage their disease. We are very encouraged by CMS’s proposed rule and commend the agency on taking action to help more people with diabetes.

Read more >

Medtronic Announces FDA Approval for Minimed™ 770G Insulin Pump System with Smartphone Connectivity for People with Type 1 Diabetes

September 1, 2020

DUBLIN – September 1, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed™ 770G hybrid closed loop system. This newest insulin pump system offers the company’s most advanced SmartGuard™ technology, as featured in the MiniMed™ 670G system, with the added benefits of smartphone connectivity and an expanded age indication to children as young as 2.

Read more >

Medtronic Plans To Acquire Smart Insulin Pen Company Companion Medical

August 11, 2020

DUBLIN and SAN DIEGO – August 11, 2020 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA cleared smart insulin pen system paired with an integrated diabetes management app on the market. The addition of Companion Medical’s InPen to the Medtronic portfolio expands the company’s ability to serve people where they are in their diabetes journey and offer them a unique and expansive ecosystem of support — regardless of how insulin is delivered.

Read more >

Medtronic Expands Diabetes Support Programs to Help Customers Losing Insurance Coverage Due to Job Loss as a Result of COVID-19

May 06, 2020

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced an expansion of the Medtronic Assurance program with a new option to support diabetes customers who have lost their health insurance due to COVID-19-related job loss. Current eligible U.S. customers can now receive a 3-month supply of glucose sensors, infusion sets and reservoirs at no cost.

Read more >

Medtronic Gives $1 Million in Product Donations to Insulin for Life to Support COVID-19 Relief Efforts

April 30, 2020

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a $1 million product donation to Insulin for Life USA to support COVID-19 relief efforts. Medtronic will donate sensors, infusion sets and reservoirs, which will be distributed by Insulin for Life USA to patients on insulin pump therapy experiencing financial hardships as a result of COVID-19. Insulin for Life USA, with support from the Leona M. and Harry B. Helmsley Charitable Trust, will provide these supplies to approximately 15 diabetes clinics across the U.S. that serve people in need living with type 1 diabetes. Insulin for Life USA is a non-profit that supports continuity of therapy for people living with diabetes who otherwise would go without these critical and often life-saving supplies.

Read more >

View all Announcements >





Media Inquiries

For media inquiries pertaining to the Diabetes Group of Medtronic, please contact:

Janet Cho
Sr Director, Global Communications
818-576-5014
janet.cho@medtronic.com

Pamela Reese
Director, Communications
818-576-3398
pamela.s.reese@medtronic.com

For all other media inquiries please select the appropriate Global Public and Media Relations contact

Media Kits